Á¶Ç÷¸ð¼¼Æ÷À̽ÄÀÇ Á¾·ù´Â ȯÀÚÀÇ Áúº´°ú °ø¿©ÀÚÀÇ »óÅ¿¡ µû¶ó °áÁ¤µÇ´Â °ÍÀ¸·Î ¾Æ·¡¿Í °°ÀÌ ³ª´µ¾î Áý´Ï´Ù.
1) ÇüÁ¦°£ Á¶Ç÷¸ð¼¼Æ÷ÀÌ½Ä (HLA matched sibling HSCT)
ÇüÁ¦°£ÀÇ Á¶Á÷ÀûÇÕÇ׿øÀÌ ÀÏÄ¡ÇÏ´Â °ø¿©ÀÚ°¡ ÀÖÀ» °æ¿ì ÇüÁ¦·ÎºÎÅÍ °ñ¼ö¸¦ ±âÁõ ¹Þ´Â °æ¿ì¸¦ ¸»ÇÕ´Ï´Ù.
2) ºñÇ÷¿¬°£ Á¶Ç÷¸ð¼¼Æ÷ÀÌ½Ä (HLA matched Unrelated HSCT)
°¡Á· °¡¿îµ¥ Á¶Á÷ÀûÇÕÇ׿øÀÌ ÀÏÄ¡ÇÏ´Â °ø¿©ÀÚ°¡ ¾ø°Å³ª ÀÚ°¡Á¶Ç÷¸ð¼¼Æ÷ À̽ÄÀÌ ºÒ°¡´ÉÇÑ °æ¿ì °ñ¼öÀºÇàÇùȸ¿¡¼ À¯ÀüÀÚ°¡ ÀÏÄ¡ÇÏ´Â °ø¿©ÀÚ¸¦ ã¾Æ¾ß ÇÕ´Ï´Ù. ¿ì¸®³ª¶ó¿¡´Â Çѱ¹°ñ¼öÀºÇàÇùȸ(Korean Marrow Donor Program)¿Í °¡Å縯Á¶Ç÷¸ð¼¼Æ÷Á¤º¸ÀºÇà(Catholic Hemopoietic Stem Cell Information Bank) 2°³ÀÇ ±â°üÀÌ ÀÖÀ¸¸ç ±¹³»¿¡ ÀÏÄ¡ÀÚ¸¦ ãÀ» ¼ö ¾øÀ» °æ¿ì ÀϺ» ¹× ´ë¸¸À̳ª ÇØ¿Ü°ñ¼öÀºÇàÇùȸ¸¦ ÅëÇؼµµ °ñ¼ö¸¦ ãÀ» ¼ö ÀÖ½À´Ï´Ù.
3) °¡Á·³» ºÒÀÏÄ¡ Á¶Ç÷¸ð¼¼Æ÷À̽Ä(HLA mismatched family HSCT)
Á¶Á÷ÀûÇÕÇ׿øÀÌ ÀÏÄ¡ÇÏ´Â °ø¿©ÀÚ¸¦ ±¸ÇÒ ¼ö ¾ø°Å³ª ÀÚ°¡ÀÌ½Ä ±âÁØ¿¡ ÀûÇÕÇÏÁö ¾ÊÀº °æ¿ì À¯»çÇÑ °¡Á·°£ÀÇ °ñ¼ö¸¦ ¼¼Æ÷󸮰úÁ¤À» °ÅÄ£ ÈÄ À̽ÄÇÏ´Â ±â¹ýÀ̳ª ¾ÆÁ÷ º¸ÆíȵÇÁö´Â ¾Ê¾Ò°í ÇöÀç´Â º¸Çè±Þ¿© ´ë»ó¿¡¼ Á¦¿ÜµË´Ï´Ù.
4) Á¦´ëÇ÷ Á¶Ç÷¸ð¼¼Æ÷ÀÌ½Ä (Cord Blood HSCT)
ÇÙ°¡Á·È, °ñ¼ö±âÁõ °ÅºÎ µîÀ¸·Î °ø¿©ÀÚÀÇ È®º¸°¡ ºÎÁ·ÇÏ°Ô µÇ¸é¼ ÃÖ±ÙÁ¦´ëÇ÷ Á¶Ç÷¸ð¼¼Æ÷À̽Ŀ¡ ´ëÇÑ °ü½ÉÀÌ Áõ°¡µÇ°í ÀÖ½À´Ï´Ù. Á¦´ëÇ÷ Á¶Ç÷¸ð¼¼Æ÷´Â Ãâ»ê ÈÄ Å¹ݰú ÅÈÁÙ¿¡¼ ¸ð¾ÆÁý´Ï´Ù. Á¦´ëÇ÷¿¡¼ ÃßÃâÇÑ Á¶Ç÷¸ð¼¼Æ÷ÀÇ ¾çÀÌ ¸Å¿ì Àû¾î ÇöÀç´Â ¼Ò¾Æ¿¡°Ô ÁÖ·Î ½ÃÇàµÇ°í ÀÖÀ¸¸ç ¼ºÀο¡°Ô´Â ¾ÆÁ÷ º¸ÆíȵÇÁö ¾Ê°í ÀÖ½À´Ï´Ù.
5) ¹Ì´Ï À̽Ä(Non-Myeloablative Stem Cell Transplantation)
¹Ì´ÏÀ̽ÄÀº À̽ÄÀÇ ÃֽŠ±â¹ý Áß Çϳª·Î Ç¥ÁØÀ̽Ŀ¡ ºñÇØ »ó´ëÀûÀ¸·Î Àú¿ë·®ÀÇ Ç×¾ÏÁ¦°¡ Åõ¿© µË´Ï´Ù. ÀÏÁ¤±â°£µ¿¾È ȯÀÚÀÇ ½Åü ³»¿¡´Â ¾Ï¼¼Æ÷¿Í ±×¿¡ ÀúÇ×ÇÏ´Â °ø¿©ÀÚÀÇ ¼¼Æ÷°¡ °øÁ¸ÇÏ°Ô µË´Ï´Ù. ÀÌ ±â¹ýÀº °í¿¬·ÉÀ̰ųª Ç¥ÁØÀ̽ÄÀ» Àû¿ëÇϱ⠾î·Á¿î ȯÀÚµµ Àû¿ëÀÌ °¡´ÉÇÕ´Ï´Ù.
6) ÀÚ°¡Á¶Ç÷¸ð¼¼Æ÷ ÀÌ½Ä (Autologous HSCT)
ȯÀÚ ÀÚ½ÅÀÇ °ñ¼ö ¹× ¸»ÃÊÁ¶Ç÷¸ð¼¼Æ÷¸¦ ÀÌ¿ëÇÏ´Â °ÍÀ̸ç, °¡´ÉÇÑ Áúº´ÀÇ »óÅ°¡ °üÇØ »óÅ¿¡¼ ¸»ÃÊÇ÷¾×À̳ª °ñ¼ö¿¡¼ Á¶Ç÷¸ð¼¼Æ÷¸¦ äÃëÇÑ µÚ ³Ãµ¿º¸°ü ÈÄ ÀÌ½Ä ½Ã Çص¿ ÈÄ ÀçÁÖÀÔÇÏ´Â °ÍÀÔ´Ï´Ù.